Luba Greenwood

Luba Greenwood

Direktor/Vorstandsmitglied bei IN8BIO, INC.

Vermögen: 16 424 $ am 31.05.2026

47 Jahre
Health Technology
Finance
Consumer Services

Profil

Luba Greenwood was the founder of LUCA Biologics, Inc., founded in 2019, serving as Chief Executive Officer & Director from 2019 to 2021.
Ms. Greenwood is also the founder of Pharma Digital Health Roundtable..
Ms. Greenwood is a Non-Executive Director at Abcam Ltd. (United Kingdom) since 2022.
Ms. Greenwood is a Director at Massachusetts Biotechnology Council, Entrinsic, Inc. (Massachusetts), and Scinapsis Analytics, Inc. since 2021.
Ms. Greenwood is an Independent Director at Os Acquisition Corp.
and IN8bio, Inc. since 2021.
Ms. Greenwood is a Professor at Harvard University since 2019.
Ms. Greenwood is an Advisor at CHV Management LLC, Van Leer Xenia Ventures, and Stuff That Works Ltd. since 2021.
Ms. Greenwood is a Managing Partner at Dana-Farber, Inc., Binney Street Capital since 2020, and Cathay Capital Private Equity SAS. Ms. Greenwood is a Senior Advisor at Grove Ventures Capital (GP) Ltd. Ms. Greenwood is a Member of the Massachusetts Board of Bar Overseers.
Former positions include Director at IRX Therapeutics, Inc., Longwood Symphony Orchestra, Inc. in 2016, Brooklyn Immunotherapeutics Investors LP from 2017 to 2022, Kojin Therapeutics, Inc. in 2021, Ernexa Therapeutics, Inc. from 2021 to 2022, and Traws Pharma, Inc. in 2024.
Senior counsel at Pfizer Inc. from 2011 to 2014.
Vice President-Global Business Development at F.
Hoffmann-La Roche Ltd. and Roche Holding AG from 2015 to 2018.
Venture partner at Colt Ventures Ltd. in 2015.
Vice president at Axcella Health, Inc. from 2014 to 2015.
Head-Strategic Business Development at Verily Life Sciences LLC from 2018 to 2019.
Executive Managing Partner at Dana-Farber Cancer Institute, Inc. from 2019 to 2024.
Senior Associate at WilmerHale LLP from 2004 to 2011.
Managing Partner at The Cathay Capital Group.
Education includes undergraduate degree from Brandeis University and graduate degree from Northeastern University School of Law.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
09.05.2026 8 783 ( 0,09 % ) 16 424 $ 31.05.2026

Aktive Positionen von Luba Greenwood

UnternehmenPositionBeginn
IN8BIO, INC. Direktor/Vorstandsmitglied 01.07.2021
ABCAM PLC Direktor/Vorstandsmitglied 12.09.2022
Berater -
Corporate Officer/Principal 01.06.2019
Corporate Officer/Principal -
Berater 01.01.2021
Berater -
Berater -
Private Equity Investor -
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Luba Greenwood

UnternehmenPositionEnde
░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Luba Greenwood im Detail an

Ausbildung von Luba Greenwood

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

66

Beziehungen ersten Grades

34

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Finance

Commercial Services

Finance

Finance

Health Technology

Consumer Services

Finance

Technology Services

Technology Services

Finance

Technology Services

Commercial Services

Health Technology

Finance

The Cathay Capital Group

Health Technology

Health Technology

Technology Services

Finance

Health Technology

Finance

Pharma Digital Health Roundtable

Commercial Services

Consumer Services

  1. Börse
  2. Insiders
  3. Luba Greenwood
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT